NP / PA
Riedl, Elza
Riedl, Elza was paid $29K by Medicaid between Aug 2022 and Mar 2023, across 11 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoRIEDL, ELZA
BRAINTREE, MA 02184
BRAINTREE, MA 02184
33aNPI1245419035assigned 10/29/2007
33bProvider typeNurse Practitioner
28Total paid$29K
24GClaims656
24DCodes billed11
24AFirst – last monthAug 2022 – Mar 2023
Compared with peers
Next to other Nurse Practitioner providers in Massachusetts
Rank by total paid#49 of 172
Median peer was paid$8K
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 458 | $16K | |
| 2023 | 198 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 78 | 71 | $10K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 116 | 111 | $7K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 91 | 90 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.0% | 47 | 47 | $3K |
| 99173 | 4.6% | 61 | 61 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.6% | 16 | 16 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.6% | 100 | 100 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 28 | 28 | $840.00 |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.7% | 88 | 88 | $796.40 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 18 | 18 | $307.08 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | 13 | $189.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.